Aggressive Diffuse Large B-cell Lymphoma
Oncology·MeSH: Lymphoma, Follicular
Prevalence
56.0 / 100K
Incidence
19.6 / 100K/yr
2 drugs in development·1 company·1 clinical trial
Drug Pipeline by Phase
Compare drugs
Frequently asked questions
How many drugs are in development for Aggressive Diffuse Large B-cell Lymphoma?
BioSniper tracks 2 drugs in development for Aggressive Diffuse Large B-cell Lymphoma across 1 company.
How many clinical trials target Aggressive Diffuse Large B-cell Lymphoma?
There are 1 clinical trial targeting Aggressive Diffuse Large B-cell Lymphoma tracked by BioSniper.
What is the prevalence of Aggressive Diffuse Large B-cell Lymphoma?
The estimated prevalence of Aggressive Diffuse Large B-cell Lymphoma is approximately 56.0 per 100,000 population.
Deep-dive into Aggressive Diffuse Large B-cell Lymphoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis